SCHEMBL24969137

SCHEMBL24969137

O=S(=O)(CC1CCC2(CC1)OCCO2)c1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.51
ALDH1A1 P00352 7/20 0.45
L3MBTL1 Q9Y468 2/20 0.45
TSHR P16473 1/20 0.45
RECQL P46063 1/20 0.45
ESR2 Q92731 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
CRBN Q96SW2 1/20 0.44
PSEN1 P49768 1/20 0.44
PSEN2 P49810 1/20 0.44
APH1B Q8WW43 1/20 0.44
NCSTN Q92542 1/20 0.44
APH1A Q96BI3 1/20 0.44
PSENEN Q9NZ42 1/20 0.44
MAPT P10636 4/20 0.43
GAA P10253 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.42
NPC1 O15118 1/20 0.42
HPGD P15428 1/20 0.42
HTT P42858 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21742973 0.85 LMNA (0.44) POLBALDH1A1L3MBTL1SMN1; SMN2MMP2
SCHEMBL5033753 0.79 POLB (0.41) POLBALDH1A1L3MBTL1TSHRRECQL
SCHEMBL5027380 0.79 POLB (0.41) POLBALDH1A1L3MBTL1TSHRRECQL
SCHEMBL28229855 0.79 ALDH1A1 (0.56) POLBALDH1A1CRBNPSEN1PSEN2
SCHEMBL21723106 0.77 CA1 (0.39) KDM4EPKM
SCHEMBL21743076 0.77 PSEN1 (0.40) ALDH1A1TSHRCRBNPSEN1PSEN2
SCHEMBL21743131 0.77 POLB (0.40) POLBCRBNPSEN1PSEN2APH1B
SCHEMBL2254125 0.77 ALDH1A1 (0.50) POLBALDH1A1L3MBTL1TSHRRECQL
SCHEMBL21723084 0.75 PSEN1 (0.34) POLBALDH1A1L3MBTL1ESR2PSEN1
SCHEMBL21742975 0.75 PSEN1 (0.44) CRBNPSEN1PSEN2APH1BNCSTN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12624004-B2 Opioid receptor agonist, preparation method therefor and pharmaceutical use thereof FUDAN UNIVERSITY (CN) 2026-05-12 US disclosed
US-20230027752-A1 OPIOID RECEPTOR AGONIST, PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF FUDAN UNIVERSITY (CN) 2023-01-26 US disclosed
US-20230027752-A1 OPIOID RECEPTOR AGONIST, PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF FUDAN UNIVERSITY (CN) 2023-01-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12624004-B2 Opioid receptor agonist, preparation method therefor and pharmaceutical use thereof OPRM1, OPRD1, OPRK1 POLB 2860/4885ALDH1A1 1377/4885L3MBTL1 4319/4885
US-20230027752-A1 OPIOID RECEPTOR AGONIST, PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF OPRM1, OPRD1, OPRL1 POLB 1954/4885ALDH1A1 1025/4885L3MBTL1 4566/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.